220 related articles for article (PubMed ID: 9559979)
1. Antigen-specific therapies in multiple sclerosis.
van Noort JM
Biotherapy; 1998; 10(3):237-50. PubMed ID: 9559979
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.
Stinissen P; Raus J; Zhang J
Crit Rev Immunol; 1997; 17(1):33-75. PubMed ID: 9034723
[TBL] [Abstract][Full Text] [Related]
3. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis and their application for new therapeutic strategies.
Martin R
J Neural Transm Suppl; 1997; 49():53-67. PubMed ID: 9266414
[TBL] [Abstract][Full Text] [Related]
4. Insights into the immunopathogenesis of multiple sclerosis.
Hellings N; Raus J; Stinissen P
Immunol Res; 2002; 25(1):27-51. PubMed ID: 11868933
[TBL] [Abstract][Full Text] [Related]
5. Immune tolerance to myelin proteins.
Seamons A; Perchellet A; Goverman J
Immunol Res; 2003; 28(3):201-21. PubMed ID: 14713715
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis: an altered immune response or an altered stress response?
van Noort JM
J Mol Med (Berl); 1996 Jun; 74(6):285-96. PubMed ID: 8862510
[TBL] [Abstract][Full Text] [Related]
7. The role of CD1-mediated presentation of myelin lipids in experimental autoimmune encephalomyelitis and multiple sclerosis pathologenesis.
Lyons JA
Drug News Perspect; 2003 Nov; 16(9):574-84. PubMed ID: 14702138
[TBL] [Abstract][Full Text] [Related]
8. T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.
O'Brien K; Gran B; Rostami A
Immunotherapy; 2010 Jan; 2(1):99-115. PubMed ID: 20231863
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures.
Karussis D; Slavin S
J Neurol Sci; 2004 Aug; 223(1):59-64. PubMed ID: 15261562
[TBL] [Abstract][Full Text] [Related]
10. The role of costimulation in autoimmune demyelination.
Racke MK; Ratts RB; Arredondo L; Perrin PJ; Lovett-Racke A
J Neuroimmunol; 2000 Jul; 107(2):205-15. PubMed ID: 10854658
[TBL] [Abstract][Full Text] [Related]
11. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
Stinissen P; Raus J
Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096
[TBL] [Abstract][Full Text] [Related]
12. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.
Martin R; McFarland HF
Crit Rev Clin Lab Sci; 1995; 32(2):121-82. PubMed ID: 7598789
[TBL] [Abstract][Full Text] [Related]
13. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
[TBL] [Abstract][Full Text] [Related]
14. Late complications of immune deviation therapy in a nonhuman primate.
Genain CP; Abel K; Belmar N; Villinger F; Rosenberg DP; Linington C; Raine CS; Hauser SL
Science; 1996 Dec; 274(5295):2054-7. PubMed ID: 8953031
[TBL] [Abstract][Full Text] [Related]
15. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
Ota K; Matsui M; Milford EL; Mackin GA; Weiner HL; Hafler DA
Nature; 1990 Jul; 346(6280):183-7. PubMed ID: 1694970
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.
Fontoura P; Garren H; Steinman L
Int Rev Immunol; 2005; 24(5-6):415-46. PubMed ID: 16318989
[TBL] [Abstract][Full Text] [Related]
17. MS as autoimmune disease: myelin antigens.
Fierz W
Res Immunol; 1989 Feb; 140(2):181-7; discussion 245-8. PubMed ID: 2662282
[No Abstract] [Full Text] [Related]
18. Insights into the aetiology and pathogenesis of multiple sclerosis.
Ewing C; Bernard CC
Immunol Cell Biol; 1998 Feb; 76(1):47-54. PubMed ID: 9553776
[TBL] [Abstract][Full Text] [Related]
19. [The trimolecular complex as a target for specific immunotherapy in experimental autoimmune encephalomyelitis--applications for multiple sclerosis and other human autoimmune disease].
Miller A; Weiner HL; Abramsky O
Harefuah; 1992 Aug; 123(3-4):110-5. PubMed ID: 1516860
[No Abstract] [Full Text] [Related]
20. Multiple sclerosis as a disease of immune regulation.
Waksman BH; Reynolds WE
Proc Soc Exp Biol Med; 1984 Mar; 175(3):282-94. PubMed ID: 6229799
[No Abstract] [Full Text] [Related]
[Next] [New Search]
